Jagsonpal Pharmaceuticals has entered into a business transfer agreement (BTA) with Group Pharmaceuticals to acquire its wellness portfolio on a going-concern basis through a slump sale. For the full story, visit the source.
Business
Jagsonpal Pharma to acquire Group Pharmaceuticals' wellness portfolio
Jagsonpal Pharmaceuticals has entered into a business transfer agreement (BTA) with Group Pharmaceuticals to acquire its wellness portfolio on a going-concern basis through a slump sale.
By Capital Market· Business Standard· 10 days ago· 2 min read
This summary is sourced from Business Standard. Read the full article at:Business Standard